Description
Cartalax is a synthetic tripeptide research compound from the Khavinson bioregulator series. It is supplied as a high-purity lyophilized powder for laboratory use only.
The compound is typically described by the sequence Ala-Glu-Asp. Reported specifications commonly include a molecular weight of approximately 333 g/mol and a molecular formula of C₁₂H₁₉N₃O₈. Identity and purity are confirmed by HPLC and mass spectrometry.
In laboratory and preclinical research, Cartalax has been investigated for effects on connective-tissue and chondrocyte-related signaling, including studies of fibroblast activity, cartilage-matrix models, and cellular-aging pathways in experimental systems. These findings are limited to research settings and do not establish approved medical use.
This material is not approved for human or veterinary use and is not intended for consumption.
Reviews
There are no reviews yet.